

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 6.37385809 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.37385809 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.37385809 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.37385809 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 6.37385809 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 6.37385809 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.22444394 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.18461968 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.59301793 |
| 10 | response to peptidoglycan (GO:0032494) | 4.39513648 |
| 11 | detection of other organism (GO:0098543) | 4.35823564 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.35387255 |
| 13 | positive regulation of interferon-alpha production (GO:0032727) | 4.34424953 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.33380709 |
| 15 | immunoglobulin mediated immune response (GO:0016064) | 4.32865803 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.29980614 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.24995511 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.24995511 |
| 19 | response to host immune response (GO:0052572) | 4.21178874 |
| 20 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.21178874 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.15930353 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14758079 |
| 23 | detection of bacterium (GO:0016045) | 4.05107666 |
| 24 | detection of external biotic stimulus (GO:0098581) | 3.93553559 |
| 25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.91441804 |
| 26 | response to host (GO:0075136) | 3.91441804 |
| 27 | response to host defenses (GO:0052200) | 3.91441804 |
| 28 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.86191741 |
| 29 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.80158407 |
| 30 | positive regulation of B cell differentiation (GO:0045579) | 3.67436764 |
| 31 | response to muramyl dipeptide (GO:0032495) | 3.67082515 |
| 32 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.63229456 |
| 33 | respiratory burst (GO:0045730) | 3.60927796 |
| 34 | regulation of leukocyte degranulation (GO:0043300) | 3.60722388 |
| 35 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.53559442 |
| 36 | microglial cell activation (GO:0001774) | 3.53457201 |
| 37 | detection of biotic stimulus (GO:0009595) | 3.50812430 |
| 38 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.48173391 |
| 39 | positive regulation of antigen processing and presentation (GO:0002579) | 3.47939607 |
| 40 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.39408066 |
| 41 | positive regulation of mast cell degranulation (GO:0043306) | 3.39408066 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 3.37573852 |
| 43 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.37110139 |
| 44 | amino sugar catabolic process (GO:0046348) | 3.33220314 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.30909514 |
| 46 | pinocytosis (GO:0006907) | 3.30009933 |
| 47 | macrophage activation (GO:0042116) | 3.29649474 |
| 48 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.27123624 |
| 49 | positive regulation of interferon-beta production (GO:0032728) | 3.26096341 |
| 50 | B cell mediated immunity (GO:0019724) | 3.20320593 |
| 51 | granulocyte activation (GO:0036230) | 3.16128295 |
| 52 | regulation of B cell differentiation (GO:0045577) | 3.15772361 |
| 53 | neutrophil activation (GO:0042119) | 3.14367144 |
| 54 | leukocyte aggregation (GO:0070486) | 3.14039329 |
| 55 | positive regulation of leukocyte degranulation (GO:0043302) | 3.12590352 |
| 56 | glycosphingolipid catabolic process (GO:0046479) | 3.10336567 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 3.07245516 |
| 58 | defense response to protozoan (GO:0042832) | 3.06964167 |
| 59 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06372228 |
| 60 | regulation of T cell tolerance induction (GO:0002664) | 3.04558807 |
| 61 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.01560844 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00890017 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 3.00563974 |
| 64 | cellular extravasation (GO:0045123) | 3.00280351 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 3.00110510 |
| 66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.99858063 |
| 67 | I-kappaB phosphorylation (GO:0007252) | 2.99083621 |
| 68 | myeloid dendritic cell differentiation (GO:0043011) | 2.97905826 |
| 69 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.97667549 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95896555 |
| 71 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.95773589 |
| 72 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.95664224 |
| 73 | myeloid dendritic cell activation (GO:0001773) | 2.94704936 |
| 74 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.94623945 |
| 75 | regulation of regulated secretory pathway (GO:1903305) | 2.93123590 |
| 76 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92767191 |
| 77 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.92491520 |
| 78 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.92432418 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 2.92416767 |
| 80 | natural killer cell mediated immunity (GO:0002228) | 2.91625603 |
| 81 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.91625603 |
| 82 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.91297967 |
| 83 | negative regulation of cell killing (GO:0031342) | 2.91297967 |
| 84 | response to type I interferon (GO:0034340) | 2.91241049 |
| 85 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.90117975 |
| 86 | negative regulation of interleukin-17 production (GO:0032700) | 2.90021891 |
| 87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.89839576 |
| 88 | regulation of tolerance induction (GO:0002643) | 2.89214296 |
| 89 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.89173278 |
| 90 | type I interferon signaling pathway (GO:0060337) | 2.89053216 |
| 91 | cellular response to type I interferon (GO:0071357) | 2.89053216 |
| 92 | regulation of mast cell activation (GO:0033003) | 2.87121252 |
| 93 | germinal center formation (GO:0002467) | 2.87041018 |
| 94 | neutrophil mediated immunity (GO:0002446) | 2.86638343 |
| 95 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.86445191 |
| 96 | B cell receptor signaling pathway (GO:0050853) | 2.86392790 |
| 97 | N-acetylneuraminate metabolic process (GO:0006054) | 2.85268111 |
| 98 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.84656609 |
| 99 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.84568349 |
| 100 | response to protozoan (GO:0001562) | 2.84466582 |
| 101 | barbed-end actin filament capping (GO:0051016) | 2.83565224 |
| 102 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82619535 |
| 103 | regulation of mononuclear cell migration (GO:0071675) | 2.82518762 |
| 104 | positive regulation of mast cell activation (GO:0033005) | 2.82480131 |
| 105 | negative regulation of mast cell activation (GO:0033004) | 2.81641202 |
| 106 | leukocyte cell-cell adhesion (GO:0007159) | 2.81290718 |
| 107 | regulation of macrophage cytokine production (GO:0010935) | 2.80172092 |
| 108 | regulation of chemokine biosynthetic process (GO:0045073) | 2.79518491 |
| 109 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78734882 |
| 110 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76182309 |
| 111 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.76160079 |
| 112 | glycolipid catabolic process (GO:0019377) | 2.75836689 |
| 113 | neutrophil chemotaxis (GO:0030593) | 2.75270785 |
| 114 | myeloid leukocyte activation (GO:0002274) | 2.75138174 |
| 115 | regulation of cholesterol storage (GO:0010885) | 2.72539457 |
| 116 | regulation of macrophage chemotaxis (GO:0010758) | 2.71717868 |
| 117 | dendritic cell differentiation (GO:0097028) | 2.70665236 |
| 118 | positive regulation of macrophage cytokine production (GO:0060907) | 2.70600631 |
| 119 | oligosaccharide catabolic process (GO:0009313) | 2.70345733 |
| 120 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.70162380 |
| 121 | neutrophil migration (GO:1990266) | 2.67713889 |
| 122 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.64408853 |
| 123 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.64039069 |
| 124 | regulation of integrin activation (GO:0033623) | 2.63626432 |
| 125 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.62943644 |
| 126 | response to interferon-alpha (GO:0035455) | 2.60701658 |
| 127 | negative regulation of interleukin-6 production (GO:0032715) | 2.58960812 |
| 128 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58667842 |
| 129 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.56436676 |
| 130 | superoxide anion generation (GO:0042554) | 2.56355202 |
| 131 | T-helper 1 type immune response (GO:0042088) | 2.55940081 |
| 132 | negative regulation of phagocytosis (GO:0050765) | 2.55884006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.43086565 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.20153837 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.89779026 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.77389916 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.70176703 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.64172608 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.56520966 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.43972636 |
| 9 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.36252418 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.25771537 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.20889867 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.06719406 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.86342810 |
| 14 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.82808202 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.73332047 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72558715 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71712440 |
| 18 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.43834041 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.43775990 |
| 20 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.41265685 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.37238472 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33623784 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24590421 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20831068 |
| 25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16504469 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13568192 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 2.06818873 |
| 28 | MYC_22102868_ChIP-Seq_BL_Human | 2.04956189 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.04149192 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03110256 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.97605048 |
| 32 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.97076689 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.87864400 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82019824 |
| 35 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81652482 |
| 36 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73606509 |
| 37 | MYB_26560356_Chip-Seq_TH1_Human | 1.73395737 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72476596 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.70991253 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67163877 |
| 41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.64894495 |
| 42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64472244 |
| 43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64420223 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.62763827 |
| 45 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62081634 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54153074 |
| 47 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52370393 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51201041 |
| 49 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.49151439 |
| 50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44774892 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44147479 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.43345140 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40279949 |
| 54 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.39094074 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.38379190 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37241902 |
| 57 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36566342 |
| 58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36327533 |
| 59 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36034584 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.35906055 |
| 61 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32402667 |
| 62 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31965598 |
| 63 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29442702 |
| 64 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27690753 |
| 65 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.27265371 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25354243 |
| 67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22884128 |
| 68 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22699787 |
| 69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22555538 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.21891480 |
| 71 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21743392 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21645323 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19483709 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19011027 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17342806 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.17006101 |
| 77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16652251 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15319370 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15135005 |
| 80 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14524244 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12161985 |
| 82 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12048281 |
| 83 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11913255 |
| 84 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11292245 |
| 85 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09629422 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08154647 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07378494 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 1.05914269 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03679827 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.02482903 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01728722 |
| 92 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01087885 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 1.00307739 |
| 94 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99168116 |
| 95 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98906292 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98493935 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98294193 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.96389868 |
| 99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94475757 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94376461 |
| 101 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93762657 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89435456 |
| 103 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87442437 |
| 104 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87353678 |
| 105 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87161124 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87033095 |
| 107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85289163 |
| 108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83361840 |
| 109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82637684 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82223523 |
| 111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81607268 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78696614 |
| 113 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78696614 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78107169 |
| 115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.74598891 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.96058721 |
| 2 | MP0003303_peritoneal_inflammation | 3.34949163 |
| 3 | MP0003436_decreased_susceptibility_to | 3.15146300 |
| 4 | MP0005058_abnormal_lysosome_morphology | 2.92069122 |
| 5 | MP0002419_abnormal_innate_immunity | 2.86752107 |
| 6 | MP0009785_altered_susceptibility_to | 2.82443251 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.67517626 |
| 8 | MP0006082_CNS_inflammation | 2.65310765 |
| 9 | MP0000685_abnormal_immune_system | 2.59505895 |
| 10 | MP0001790_abnormal_immune_system | 2.57240352 |
| 11 | MP0005387_immune_system_phenotype | 2.57240352 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.52155023 |
| 13 | MP0005025_abnormal_response_to | 2.51183361 |
| 14 | MP0004510_myositis | 2.46444512 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.44794651 |
| 16 | MP0001800_abnormal_humoral_immune | 2.44618559 |
| 17 | MP0009278_abnormal_bone_marrow | 2.40744081 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.29674886 |
| 19 | MP0003724_increased_susceptibility_to | 2.29373527 |
| 20 | MP0002723_abnormal_immune_serum | 2.27353101 |
| 21 | MP0005671_abnormal_response_to | 2.24252427 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.24098238 |
| 23 | MP0001819_abnormal_immune_cell | 2.14705823 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.14112303 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.12764970 |
| 26 | MP0003300_gastrointestinal_ulcer | 2.09738559 |
| 27 | MP0001853_heart_inflammation | 2.05386192 |
| 28 | MP0002405_respiratory_system_inflammati | 2.01252514 |
| 29 | MP0004947_skin_inflammation | 1.94206818 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.93108947 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.86863209 |
| 32 | MP0005397_hematopoietic_system_phenotyp | 1.83857927 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.83857927 |
| 34 | MP0003448_altered_tumor_morphology | 1.75345227 |
| 35 | MP0002398_abnormal_bone_marrow | 1.71750113 |
| 36 | MP0000343_altered_response_to | 1.70313060 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.63982764 |
| 38 | MP0009333_abnormal_splenocyte_physiolog | 1.63776735 |
| 39 | MP0000716_abnormal_immune_system | 1.63363805 |
| 40 | MP0009840_abnormal_foam_cell | 1.60804832 |
| 41 | MP0005451_abnormal_body_composition | 1.58316225 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.57715920 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.54156279 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.51971996 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.51845688 |
| 46 | MP0010307_abnormal_tumor_latency | 1.48389861 |
| 47 | MP0002396_abnormal_hematopoietic_system | 1.46908838 |
| 48 | MP0003566_abnormal_cell_adhesion | 1.46203681 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.43596379 |
| 50 | MP0000858_altered_metastatic_potential | 1.43284599 |
| 51 | MP0002722_abnormal_immune_system | 1.42646041 |
| 52 | MP0003705_abnormal_hypodermis_morpholog | 1.41253918 |
| 53 | MP0000465_gastrointestinal_hemorrhage | 1.40612952 |
| 54 | MP0002429_abnormal_blood_cell | 1.40526568 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.40166687 |
| 56 | MP0009764_decreased_sensitivity_to | 1.39048110 |
| 57 | MP0003075_altered_response_to | 1.39028236 |
| 58 | MP0008469_abnormal_protein_level | 1.36908997 |
| 59 | MP0003828_pulmonary_edema | 1.35975877 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.34474684 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.30730092 |
| 62 | MP0005310_abnormal_salivary_gland | 1.28063239 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.27152472 |
| 64 | MP0002006_tumorigenesis | 1.25738294 |
| 65 | MP0002933_joint_inflammation | 1.24158596 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.22637564 |
| 67 | MP0001958_emphysema | 1.22346569 |
| 68 | MP0001851_eye_inflammation | 1.17945323 |
| 69 | MP0001873_stomach_inflammation | 1.17754646 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.16172241 |
| 71 | MP0003279_aneurysm | 1.13332971 |
| 72 | MP0000604_amyloidosis | 1.12983978 |
| 73 | MP0002254_reproductive_system_inflammat | 1.11597435 |
| 74 | MP0000490_abnormal_crypts_of | 1.09653538 |
| 75 | MP0008004_abnormal_stomach_pH | 1.08802805 |
| 76 | MP0005257_abnormal_intraocular_pressure | 1.07641198 |
| 77 | MP0005023_abnormal_wound_healing | 1.07202776 |
| 78 | MP0003763_abnormal_thymus_physiology | 1.04268196 |
| 79 | MP0003091_abnormal_cell_migration | 1.04239411 |
| 80 | MP0003329_amyloid_beta_deposits | 1.03021348 |
| 81 | MP0005166_decreased_susceptibility_to | 1.02988594 |
| 82 | MP0005390_skeleton_phenotype | 1.01493345 |
| 83 | MP0000920_abnormal_myelination | 0.95386079 |
| 84 | MP0003806_abnormal_nucleotide_metabolis | 0.95116695 |
| 85 | MP0000767_abnormal_smooth_muscle | 0.93839181 |
| 86 | MP0003045_fibrosis | 0.92441225 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.91151893 |
| 88 | MP0006054_spinal_hemorrhage | 0.90089928 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.89916639 |
| 90 | MP0000249_abnormal_blood_vessel | 0.87573362 |
| 91 | MP0005164_abnormal_response_to | 0.87536110 |
| 92 | MP0003690_abnormal_glial_cell | 0.87244904 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.85400452 |
| 94 | MP0002132_abnormal_respiratory_system | 0.85194243 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.84020128 |
| 96 | MP0009763_increased_sensitivity_to | 0.83024839 |
| 97 | MP0000371_diluted_coat_color | 0.76939069 |
| 98 | MP0001849_ear_inflammation | 0.76181111 |
| 99 | MP0001542_abnormal_bone_strength | 0.74203051 |
| 100 | MP0002139_abnormal_hepatobiliary_system | 0.74201873 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.73040330 |
| 102 | MP0003795_abnormal_bone_structure | 0.72896954 |
| 103 | MP0003866_abnormal_defecation | 0.72240174 |
| 104 | MP0004883_abnormal_blood_vessel | 0.71051577 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.66963933 |
| 106 | MP0008874_decreased_physiological_sensi | 0.66565585 |
| 107 | MP0002877_abnormal_melanocyte_morpholog | 0.65437900 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.64194443 |
| 109 | MP0004381_abnormal_hair_follicle | 0.62239295 |
| 110 | MP0005165_increased_susceptibility_to | 0.62037245 |
| 111 | MP0002019_abnormal_tumor_incidence | 0.61085332 |
| 112 | MP0000733_abnormal_muscle_development | 0.59189857 |
| 113 | MP0008260_abnormal_autophagy | 0.58749516 |
| 114 | MP0001915_intracranial_hemorrhage | 0.57554319 |
| 115 | MP0001663_abnormal_digestive_system | 0.54941022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.22726545 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.50690005 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.43442402 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.97036530 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.51861955 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.41790996 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.37676624 |
| 8 | Myositis (HP:0100614) | 4.29807353 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.25372524 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.03173154 |
| 11 | Mediastinal lymphadenopathy (HP:0100721) | 3.86322375 |
| 12 | Orchitis (HP:0100796) | 3.76455402 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.60210647 |
| 14 | Autoimmune thrombocytopenia (HP:0001973) | 3.50972091 |
| 15 | Recurrent skin infections (HP:0001581) | 3.47059524 |
| 16 | Obstructive lung disease (HP:0006536) | 3.44702762 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.44702762 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.37793289 |
| 19 | Optic neuritis (HP:0100653) | 3.37793289 |
| 20 | Recurrent fungal infections (HP:0002841) | 3.36383204 |
| 21 | Cellulitis (HP:0100658) | 3.32939527 |
| 22 | Stomatitis (HP:0010280) | 3.32679328 |
| 23 | Gingivitis (HP:0000230) | 3.27169557 |
| 24 | Dysostosis multiplex (HP:0000943) | 3.18596030 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.15330461 |
| 26 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.15330461 |
| 27 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.15330461 |
| 28 | Recurrent viral infections (HP:0004429) | 3.08571472 |
| 29 | Vasculitis (HP:0002633) | 2.98249309 |
| 30 | Chronic otitis media (HP:0000389) | 2.92428041 |
| 31 | Amyloidosis (HP:0011034) | 2.88347938 |
| 32 | Pustule (HP:0200039) | 2.87048920 |
| 33 | Petechiae (HP:0000967) | 2.83415360 |
| 34 | Hematochezia (HP:0002573) | 2.80328560 |
| 35 | Interstitial pulmonary disease (HP:0006530) | 2.78471398 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.73846590 |
| 37 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72190410 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.72190410 |
| 39 | Loss of speech (HP:0002371) | 2.71809908 |
| 40 | Periodontitis (HP:0000704) | 2.69680007 |
| 41 | Mutism (HP:0002300) | 2.68537204 |
| 42 | Meningitis (HP:0001287) | 2.65059447 |
| 43 | Colitis (HP:0002583) | 2.63135914 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60839044 |
| 45 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60839044 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60839044 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 2.59448872 |
| 48 | Urticaria (HP:0001025) | 2.55911436 |
| 49 | Axonal loss (HP:0003447) | 2.55580406 |
| 50 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.55560544 |
| 51 | Recurrent cutaneous fungal infections (HP:0011370) | 2.55560544 |
| 52 | Myocardial infarction (HP:0001658) | 2.55342350 |
| 53 | Arterial thrombosis (HP:0004420) | 2.53941724 |
| 54 | Disinhibition (HP:0000734) | 2.51900306 |
| 55 | Osteomyelitis (HP:0002754) | 2.51282422 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.51244565 |
| 57 | Inflammation of the large intestine (HP:0002037) | 2.50515424 |
| 58 | Prostate neoplasm (HP:0100787) | 2.49991835 |
| 59 | Nasal polyposis (HP:0100582) | 2.49614935 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.49393837 |
| 61 | Abnormality of the nasal mucosa (HP:0000433) | 2.49178789 |
| 62 | Increased IgE level (HP:0003212) | 2.46089398 |
| 63 | Leukocytosis (HP:0001974) | 2.43204649 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.42098267 |
| 65 | Gastrointestinal inflammation (HP:0004386) | 2.39894711 |
| 66 | Osteolytic defects of the hand bones (HP:0009699) | 2.39526387 |
| 67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39526387 |
| 68 | Upper motor neuron abnormality (HP:0002127) | 2.36304595 |
| 69 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.34754639 |
| 70 | Vertebral compression fractures (HP:0002953) | 2.31307735 |
| 71 | Prolonged bleeding time (HP:0003010) | 2.30240642 |
| 72 | Encephalitis (HP:0002383) | 2.30070561 |
| 73 | Tetraparesis (HP:0002273) | 2.29306757 |
| 74 | Thrombocytosis (HP:0001894) | 2.27819108 |
| 75 | Emphysema (HP:0002097) | 2.26262114 |
| 76 | Basal ganglia calcification (HP:0002135) | 2.25503146 |
| 77 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.25415335 |
| 78 | Neuronal loss in central nervous system (HP:0002529) | 2.24824099 |
| 79 | Glomerulonephritis (HP:0000099) | 2.23410438 |
| 80 | Hemoptysis (HP:0002105) | 2.21139649 |
| 81 | Gingival bleeding (HP:0000225) | 2.18168593 |
| 82 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.16489004 |
| 83 | Impaired platelet aggregation (HP:0003540) | 2.15264019 |
| 84 | Abnormal platelet function (HP:0011869) | 2.15264019 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.11247103 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 2.10933010 |
| 87 | T lymphocytopenia (HP:0005403) | 2.10460871 |
| 88 | Hepatosplenomegaly (HP:0001433) | 2.09235072 |
| 89 | Epistaxis (HP:0000421) | 2.07422220 |
| 90 | Premature loss of primary teeth (HP:0006323) | 2.07384588 |
| 91 | Thick nail (HP:0001805) | 2.04163528 |
| 92 | Progressive neurologic deterioration (HP:0002344) | 2.03930177 |
| 93 | Pulmonary embolism (HP:0002204) | 2.03271877 |
| 94 | Nuclear cataract (HP:0100018) | 2.02583840 |
| 95 | Episodic fever (HP:0001954) | 2.01426126 |
| 96 | Cerebral aneurysm (HP:0004944) | 2.01065128 |
| 97 | IgM deficiency (HP:0002850) | 2.00890553 |
| 98 | Diminished motivation (HP:0000745) | 2.00466675 |
| 99 | Pathologic fracture (HP:0002756) | 1.99883672 |
| 100 | Recurrent pneumonia (HP:0006532) | 1.98611117 |
| 101 | Peritonitis (HP:0002586) | 1.98186167 |
| 102 | Restrictive lung disease (HP:0002091) | 1.97788566 |
| 103 | Apathy (HP:0000741) | 1.97335827 |
| 104 | Nephritis (HP:0000123) | 1.96789729 |
| 105 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95565486 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 1.94125858 |
| 107 | Albinism (HP:0001022) | 1.93132597 |
| 108 | Polycythemia (HP:0001901) | 1.92667488 |
| 109 | Spondylolisthesis (HP:0003302) | 1.92382899 |
| 110 | Abnormality of iron homeostasis (HP:0011031) | 1.92323313 |
| 111 | Abnormality of T cell number (HP:0011839) | 1.92149543 |
| 112 | Agnosia (HP:0010524) | 1.91725185 |
| 113 | Purpura (HP:0000979) | 1.91281377 |
| 114 | Polyneuropathy (HP:0001271) | 1.91078226 |
| 115 | Thoracic kyphosis (HP:0002942) | 1.88116486 |
| 116 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87266913 |
| 117 | Increased IgM level (HP:0003496) | 1.86989968 |
| 118 | Cerebral inclusion bodies (HP:0100314) | 1.86811483 |
| 119 | Abnormality of the pleura (HP:0002103) | 1.85535430 |
| 120 | Increased CSF protein (HP:0002922) | 1.85352759 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 1.85311013 |
| 122 | Keratoconjunctivitis (HP:0001096) | 1.85261071 |
| 123 | Malnutrition (HP:0004395) | 1.84370824 |
| 124 | Increased density of long bones (HP:0006392) | 1.83695609 |
| 125 | Increased serum ferritin (HP:0003281) | 1.83543271 |
| 126 | Chest pain (HP:0100749) | 1.81441828 |
| 127 | Agammaglobulinemia (HP:0004432) | 1.80144138 |
| 128 | Abnormality of the pericardium (HP:0001697) | 1.79628166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.60990306 |
| 2 | TBK1 | 3.21649189 |
| 3 | KIT | 3.07783959 |
| 4 | BLK | 2.97635625 |
| 5 | PRPF4B | 2.81786489 |
| 6 | ERN1 | 2.73089191 |
| 7 | TYK2 | 2.72937874 |
| 8 | MAP3K14 | 2.70504361 |
| 9 | RIPK4 | 2.65655876 |
| 10 | IRAK4 | 2.56169157 |
| 11 | IRAK3 | 2.25949140 |
| 12 | IKBKE | 2.22677347 |
| 13 | JAK3 | 2.17550195 |
| 14 | TGFBR2 | 2.05741708 |
| 15 | ZAP70 | 2.03825795 |
| 16 | IKBKB | 2.00811908 |
| 17 | TRIB3 | 1.97249730 |
| 18 | TXK | 1.95744379 |
| 19 | CSF1R | 1.89150710 |
| 20 | EPHB1 | 1.71046605 |
| 21 | JAK1 | 1.67077668 |
| 22 | STK10 | 1.61869526 |
| 23 | BTK | 1.58990307 |
| 24 | CSK | 1.57809699 |
| 25 | HCK | 1.57459448 |
| 26 | MAP2K3 | 1.55366909 |
| 27 | PIM2 | 1.54278784 |
| 28 | TAOK3 | 1.54135111 |
| 29 | SYK | 1.53005917 |
| 30 | TTN | 1.51963101 |
| 31 | TNK2 | 1.46515723 |
| 32 | GRK7 | 1.46366973 |
| 33 | RPS6KA4 | 1.40362852 |
| 34 | MAP3K10 | 1.33728329 |
| 35 | DDR2 | 1.32037201 |
| 36 | MAP3K1 | 1.29063453 |
| 37 | CHUK | 1.28450332 |
| 38 | CDC42BPA | 1.28367417 |
| 39 | TEC | 1.26218304 |
| 40 | NME2 | 1.20494612 |
| 41 | PIM1 | 1.19371066 |
| 42 | FES | 1.19191433 |
| 43 | LCK | 1.18377886 |
| 44 | LRRK2 | 1.17957892 |
| 45 | PKN2 | 1.17318415 |
| 46 | RIPK1 | 1.14897795 |
| 47 | PTK6 | 1.14202552 |
| 48 | LYN | 1.11527542 |
| 49 | NEK9 | 1.09352662 |
| 50 | KSR2 | 1.05415852 |
| 51 | MATK | 1.04403770 |
| 52 | KDR | 1.03974282 |
| 53 | EEF2K | 1.03441031 |
| 54 | SIK2 | 1.02011058 |
| 55 | TESK2 | 1.01818127 |
| 56 | CDK12 | 0.97959456 |
| 57 | JAK2 | 0.95627540 |
| 58 | PRKD2 | 0.95066468 |
| 59 | TRPM7 | 0.94848930 |
| 60 | CAMK1D | 0.94405512 |
| 61 | ITK | 0.93720626 |
| 62 | BMX | 0.93554873 |
| 63 | MARK2 | 0.91233003 |
| 64 | MARK3 | 0.91028680 |
| 65 | PAK4 | 0.89180017 |
| 66 | FGR | 0.88465254 |
| 67 | CAMKK2 | 0.88017861 |
| 68 | MAP3K13 | 0.86880338 |
| 69 | PDPK1 | 0.84564705 |
| 70 | STK4 | 0.84108412 |
| 71 | CLK1 | 0.82415332 |
| 72 | FLT3 | 0.80189324 |
| 73 | IRAK2 | 0.79764820 |
| 74 | FGFR4 | 0.76958969 |
| 75 | SMG1 | 0.76116384 |
| 76 | CDK6 | 0.75886620 |
| 77 | SCYL2 | 0.75695935 |
| 78 | GRK6 | 0.74732765 |
| 79 | MAPK12 | 0.71964080 |
| 80 | MAP3K3 | 0.71627803 |
| 81 | MAP3K6 | 0.70889594 |
| 82 | FGFR3 | 0.70730501 |
| 83 | MAPK7 | 0.69642107 |
| 84 | IRAK1 | 0.68828661 |
| 85 | ABL1 | 0.63221160 |
| 86 | BMPR2 | 0.62040468 |
| 87 | RPS6KA6 | 0.61322342 |
| 88 | EGFR | 0.60206288 |
| 89 | STK3 | 0.58729989 |
| 90 | MAP3K11 | 0.55757064 |
| 91 | NEK2 | 0.54420342 |
| 92 | MAPKAPK2 | 0.54017325 |
| 93 | ACVR1B | 0.51574902 |
| 94 | PRKCD | 0.50818332 |
| 95 | DAPK2 | 0.48364125 |
| 96 | RPS6KL1 | 0.48234449 |
| 97 | RPS6KC1 | 0.48234449 |
| 98 | TGFBR1 | 0.43373896 |
| 99 | CAMK1G | 0.43007095 |
| 100 | CAMKK1 | 0.42951906 |
| 101 | CDK9 | 0.42763918 |
| 102 | SIK3 | 0.41950999 |
| 103 | MAP3K8 | 0.41460912 |
| 104 | EPHA3 | 0.41449026 |
| 105 | MOS | 0.41338589 |
| 106 | CDK4 | 0.41083351 |
| 107 | TAOK2 | 0.40260561 |
| 108 | MAP3K5 | 0.39682098 |
| 109 | PDGFRB | 0.39365663 |
| 110 | SGK3 | 0.38750456 |
| 111 | PDGFRA | 0.38226510 |
| 112 | PIK3CG | 0.38125671 |
| 113 | ARAF | 0.38021476 |
| 114 | RPS6KA2 | 0.36917375 |
| 115 | TESK1 | 0.36588347 |
| 116 | ABL2 | 0.36096182 |
| 117 | MAP3K2 | 0.35297731 |
| 118 | DMPK | 0.35291177 |
| 119 | DYRK1B | 0.34472307 |
| 120 | PAK2 | 0.33305700 |
| 121 | FYN | 0.32986334 |
| 122 | PDK1 | 0.32624238 |
| 123 | ALK | 0.31273766 |
| 124 | TAOK1 | 0.30340087 |
| 125 | PRKCH | 0.30073166 |
| 126 | YES1 | 0.29192614 |
| 127 | PRKG2 | 0.29188026 |
| 128 | MAPK4 | 0.28362012 |
| 129 | SIK1 | 0.27531517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.28088272 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.66484179 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54278886 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.43663777 |
| 5 | Malaria_Homo sapiens_hsa05144 | 2.42647018 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.41006179 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.21713671 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.18609759 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.11850319 |
| 10 | Pertussis_Homo sapiens_hsa05133 | 2.10981232 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 2.05134918 |
| 12 | Legionellosis_Homo sapiens_hsa05134 | 2.04443185 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.99711760 |
| 14 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93043018 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82097206 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80178062 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75498884 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.72335922 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71728186 |
| 20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.70984887 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.67740147 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.65196347 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61845436 |
| 24 | Apoptosis_Homo sapiens_hsa04210 | 1.61798805 |
| 25 | Influenza A_Homo sapiens_hsa05164 | 1.61718520 |
| 26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58633092 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.58190897 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.55130874 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.54996082 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.53748655 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.53312897 |
| 32 | Allograft rejection_Homo sapiens_hsa05330 | 1.51448632 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49776317 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.47580849 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42807209 |
| 36 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42029932 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35257373 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.33304324 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30345035 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.29232958 |
| 41 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.26880675 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.25864655 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24772128 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23341728 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18846667 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.16729365 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13887204 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.13222402 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12631155 |
| 50 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08673885 |
| 51 | Amoebiasis_Homo sapiens_hsa05146 | 1.04384135 |
| 52 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03988866 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03113547 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 1.00839386 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98595266 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.92763607 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.91925132 |
| 58 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89598767 |
| 59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87369358 |
| 60 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84695238 |
| 61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83585819 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80202931 |
| 63 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78192936 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76269342 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.76191712 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72435723 |
| 67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72319594 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70136821 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67035600 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66665731 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66453624 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65257181 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64615872 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62990110 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62914335 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62341559 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61852535 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61710758 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.59619974 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59040688 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.58748753 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.56556437 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55931866 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52235006 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52024852 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51999279 |
| 87 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51150603 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.49187654 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49167278 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49031919 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.45398463 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44380930 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41884455 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38283568 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37942097 |
| 96 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37249889 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36992216 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35546349 |
| 99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35381385 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.33671040 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30608113 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.30437152 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29986204 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.29687413 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.28315282 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27074074 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.24854231 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24814715 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23799092 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23634876 |
| 111 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.23546131 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23034867 |

